Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Diabetic Retinopathy Market Size, Trends, Shares, Insights and Forecast – 2018-2026Diabetic Retinopathy Market Report Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
Diabetic retinopathy is one of the complications of diabetes, in which blood vessels in the retina gets damaged due to high blood glucose level. Retina is the light sensitive inner lining at the back of the eye. Diabetic retinopathy mostly affects both the eyes. The line of treatment for diabetic retinopathy depending on the disease condition of the patient, may require laser surgery, intraocular injections, and anti (VEFG) vascular endothelial growth factor therapy. Global Diabetic Retinopathy - Market Dynamics Increasing incidence of diabetes along with increasing cases of blindness due to diabetes are expected to drive the diabetic retinopathy market growth. According to the International Diabetic Federation report, 2017, around 425 million adults of age group 20 to 79 years are suffering from diabetes. * The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology. Request a sample copy of this report: https://www.coherentmarketinsights.com/ Global Diabetic Retinopathy Market - Regional Insights On the basis of geography, the global diabetes retinopathy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America accounted for the largest market share in diabetes retinopathy market, owing to high prevalence of diabetic retinopathy in the region. Europe also exhibits high growth in diabetes retinopathy market due to high prevalence of diabetic retinopathy. According to a report presented by the University of Bonn, 2017, around 17.7% of diabetic patients have showed signs of moderate non-proliferative diabetic retinopathy while around 2% patients are affected by severe non-proliferative diabetic retinopathy in the Europe. Browse Research Report: https://www.coherentmarketinsights.com/ Asia Pacific region is also witnessing lucrative growth in diabetic retinopathy market due to increasing disposable income, large patient pool, and innovation in diagnostic approach and government health insurance policies. Key players operating in the global diabetic retinopathy market include Novartis AG, Regeneron Pharmaceuticals, Bayer Healthcare, Actavis Plc, Alimera Science, Pfizer Inc., Hoffmann-La Roche Ltd, Abbott Laboratories Ltd, Sirnaomics, Glycadia pharmaceuticals, Boehringer Ingelheim, Therapeutics Inc, Ampio pharmaceuticals, Lupin ltd, and others. Buy-Now this research report: https://www.coherentmarketinsights.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|